Cover Image
市場調查報告書

Aegis Therapeutics, LLC:產品平台分析

Aegis Therapeutics, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253799
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Aegis Therapeutics, LLC:產品平台分析 Aegis Therapeutics, LLC - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 21 Pages
簡介

Aegis Therapeutics, LLC 是致力於藥物輸送及製劑技術的研究開發的生物科技企業,透過提供別人許可授權發展新的藥物輸送及蛋白質穩定技術的商品化。

本報告提供Aegis Therapeutics, LLC的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、各分子類型的治療藥評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Aegis Therapeutics, LLC的基本資料

  • Aegis Therapeutics, LLC概要
  • 主要資訊
  • 企業資料

Aegis Therapeutics, LLC:R&D概要

  • 主要的治療範圍

Aegis Therapeutics, LLC:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Aegis Therapeutics, LLC:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

Aegis Therapeutics, LLC:藥物簡介

  • AFPep
  • interferon beta
  • OB-3
  • octreotide

Aegis Therapeutics, LLC:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aegis Therapeutics, LLC:最近的開發平台趨勢

Aegis Therapeutics, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06901CDB

Summary

Global Markets Direct's, 'Aegis Therapeutics, LLC - Product Pipeline Review - 2015', provides an overview of the Aegis Therapeutics, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aegis Therapeutics, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aegis Therapeutics, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aegis Therapeutics, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aegis Therapeutics, LLC's pipeline products

Reasons to buy

  • Evaluate Aegis Therapeutics, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aegis Therapeutics, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aegis Therapeutics, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aegis Therapeutics, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aegis Therapeutics, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aegis Therapeutics, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aegis Therapeutics, LLC Snapshot
    • Aegis Therapeutics, LLC Overview
    • Key Information
    • Key Facts
  • Aegis Therapeutics, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Aegis Therapeutics, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Aegis Therapeutics, LLC - Pipeline Products Glance
    • Aegis Therapeutics, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Aegis Therapeutics, LLC - Drug Profiles
    • AFPep
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • interferon beta
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OB-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • octreotide
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aegis Therapeutics, LLC - Pipeline Analysis
    • Aegis Therapeutics, LLC - Pipeline Products by Target
    • Aegis Therapeutics, LLC - Pipeline Products by Route of Administration
    • Aegis Therapeutics, LLC - Pipeline Products by Molecule Type
    • Aegis Therapeutics, LLC - Pipeline Products by Mechanism of Action
  • Aegis Therapeutics, LLC - Recent Pipeline Updates
  • Aegis Therapeutics, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aegis Therapeutics, LLC, Key Information
  • Aegis Therapeutics, LLC, Key Facts
  • Aegis Therapeutics, LLC - Pipeline by Indication, 2015
  • Aegis Therapeutics, LLC - Pipeline by Stage of Development, 2015
  • Aegis Therapeutics, LLC - Monotherapy Products in Pipeline, 2015
  • Aegis Therapeutics, LLC - Preclinical, 2015
  • Aegis Therapeutics, LLC - Pipeline by Target, 2015
  • Aegis Therapeutics, LLC - Pipeline by Route of Administration, 2015
  • Aegis Therapeutics, LLC - Pipeline by Molecule Type, 2015
  • Aegis Therapeutics, LLC - Pipeline Products by Mechanism of Action, 2015
  • Aegis Therapeutics, LLC - Recent Pipeline Updates, 2015

List of Figures

  • Aegis Therapeutics, LLC - Pipeline by Top 10 Indication, 2015
  • Aegis Therapeutics, LLC - Pipeline by Top 10 Target, 2015
  • Aegis Therapeutics, LLC - Pipeline by Top 10 Route of Administration, 2015
  • Aegis Therapeutics, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Aegis Therapeutics, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top